Drug Delivery Systems - Inhalation & Drug Development: Emerging Trends and Markets 2010

Informa Life Sciences’ 2nd annual Inhalation Drug Development conference was developed in consultation with inhalation professionals, resulting in a programme targeting the needs of the industry. By attending the 2010 conference, delegates will gain:

Extensive networking opportunities with inhalation experts, including representatives from Novartis, GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Teva and Aeropharm

Information on pertinent topics facing inhalation drug development, including improving bioequivalence and bioavailability, specific regulatory requirements for submissions in Europe and USA and optimising particle development, formulation and excipients to maximise aerosol performance and drug delivery

A unique combination of presentations focussing on advances in inhalation development, including systemic delivery, inhaled vaccines, novel targets for COPD and trends in device development